{
  "ticker": "CGF",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959328",
  "id": "02959328",
  "pages": 35,
  "price_sensitive": false,
  "date": "20250617",
  "time": "1727",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250617/pdf/06kv0vkm364ldj.pdf",
  "summary": "**Material Information Summary:**  \n\n- **Substantial Holder Change:** TAL Dai-ichi Life Australia Pty Ltd agreed to acquire **33,234,618 shares** (fully paid ordinary) in Challenger Limited (ASX: CGF) from AP Liberty GP, LLC.  \n- **Purchase Price:** **A$7.45 per share** (implied total consideration: ~A$247.6 million).  \n- **Conditions Precedent:**  \n  - FCA (UK) approval for change of control in Challenger Management Services (UK) Ltd and Fidante Partners Europe Ltd.  \n  - APRA approval for acquisition of a controlling stake in Challenger\u2019s RSE licensee subsidiaries.  \n- **Key Dates:**  \n  - **End Date for Conditions:** 4 May 2026 (or later if extended).  \n  - Completion to occur after final regulatory approval.  \n\n**Impact:** Potential change in substantial shareholding (~5.6% stake based on CGF\u2019s last disclosed shares outstanding), subject to regulatory approvals. No immediate trading impact.  \n\n*Omitted:* Legal boilerplate, warranties, and tax details (non-material to trading/capital markets).",
  "usage": {
    "prompt_tokens": 9154,
    "completion_tokens": 244,
    "total_tokens": 9398,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-17T07:51:08.589011"
}